MetLife (MET) DIvidends Date & History

Key Takeaways

• Forward dividend yield of 2.95% provides steady income in the insurance sector.
• Quarterly dividend raised to $0.5925 per share for Q2 2026, up 4.4% from prior quarter.
• Payout ratio of 47.7% supports sustainability with ample earnings coverage.
• 13 consecutive years of annual dividend increases demonstrate commitment to shareholders.
• 5-year compound annual growth rate (CAGR) of approximately 4.3% reflects reliable growth.
• Ex-dividend date of May 12, 2026, with payment on June 9, 2026.

Dividend Overview

MetLife, Inc. (MET), a leading global provider of insurance and employee benefits, maintains a quarterly dividend policy that balances income distribution with reinvestment for growth. The company recently announced a second-quarter 2026 dividend of $0.5925 per share, marking a 4.4% increase from the previous $0.5675. This brings the forward annual dividend to $2.37 per share, yielding approximately 2.95% based on a recent stock price of around $80. MetLife is positioned as a dividend growth stock rather than a high-yield play, prioritizing consistent raises over aggressive payouts. With a history of reliable payments since resuming quarterly dividends post-2011, it appeals to investors seeking stability in the cyclical insurance industry.

Dividend History and Growth

MetLife has demonstrated a strong track record of dividend growth, with quarterly payments steadily rising from $0.40 per share in 2017 to the current $0.5925. Annual totals have increased from $1.60 in 2017 to an expected $2.37 in 2026. The company has achieved 13 consecutive years of dividend increases, supported by an 8.1% compound annual growth rate since 2011. No cuts have occurred in recent history, even amid economic challenges like the COVID-19 pandemic. This progression underscores MetLife's long-term strategy of returning capital to shareholders while funding operations and strategic initiatives in its core segments of group benefits, retirement solutions, and Asia operations.

Dividend Sustainability and Payout Ratio

MetLife's dividend appears highly sustainable, with a trailing payout ratio of 47.7%, meaning less than half of earnings are distributed as dividends. This leaves significant room for growth and resilience against downturns. Trailing twelve-month (TTM) earnings per share comfortably cover the payout, and adjusted operating earnings provide even stronger support. While levered free cash flow (FCF, a measure of cash after capital expenditures) was negative at -$12.74 billion TTM—common in insurance due to reserve fluctuations—core operating cash flows and return on tangible common equity (ROTCE, a profitability metric excluding intangibles) affirm coverage. Moderate debt levels and robust capital ratios further bolster confidence in ongoing payments.

Dividend Compared to Industry Peers

MetLife's 2.95% forward yield is competitive within the insurance sector. Peers like PRU (Prudential Financial) offer higher yields around 5.9%, appealing to pure income seekers, while AIG trades at a similar ~2.1%. Property-casualty focused PGR (Progressive) yields under 1%, prioritizing growth over dividends. HIG (Hartford Financial) and CNO Financial sit around 2.3-2.5%. MetLife's profile—mid-range yield with superior growth—positions it as a balanced option relative to life and multiline insurers.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is particularly useful for identifying dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your investment strategy.

Is This Stock Attractive for Dividend Investors?

MetLife suits dividend growth investors who prioritize consistent raises and moderate yields over ultra-high payouts. Its 13-year streak of increases and 4.3% 5-year CAGR appeal to those building long-term income streams in defensive sectors like insurance. Income-oriented portfolios may find the 2.95% yield reliable, backed by a sub-50% payout ratio and diversified global operations that mitigate U.S.-centric risks. Conservative investors value the stability amid interest rate sensitivity, though cyclical credit exposures warrant monitoring. While not ideal for yield chasers favoring 5%+ payers like PRU, MetLife offers a compelling mix for balanced, patient holders seeking insurance sector exposure with capital return discipline. Volatility from macro factors like rates and claims could impact short-term appeal.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations